Safety and Immunogenicity of Cam2020 M2SR H3N2 Monovalent Influenza Vaccine Alone or With Licensed IIV in Older Adults

Clinical trial NCT05163847 · COMPLETED

Trial details

NCT number: NCT05163847
Sponsor: FluGen Inc
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Influenza Vaccine

Start date: 2022-06-14
Primary completion: 2022-11-03
Enrollment: 303

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.